ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
In 2016, J. Fraser Stoddart won the Nobel Prize in Chemistry for his part in designing a molecular machine. Now as chief technology officer and cofounder of nanotechnology firm PanaceaNano, he has introduced the “Noble” line of antiaging cosmetics, including a $524 formula described as an “anti-wrinkle repair” night cream. The firm says the cream contains Nobel Prize-winning “organic nano-cubes” loaded with ingredients that reverse skin damage and reduce the appearance of wrinkles.
Other prize-winning chemists have founded companies, but Stoddart’s backing of the antiaging cosmetic line takes the promotion of a new company by an award-winning scientist to the next level.
The nano-cubes are made of carbohydrate molecules known as cyclodextrins. The cubes, of various sizes and shapes, release ingredients such as vitamins and peptides onto the skin “at predefined times with molecular precision,” according to the Noble skin care website. PanaceaNano cofounder Youssry Botros, former nanotechnology research director at Intel, contends that the metering technology makes the product line “far superior to comparable products in the market today.” However, the nanocubes aren’t molecular machines, for which Stoddart won his Nobel prize.
While acknowledging the product line trades on his Nobel prize, Stoddart points out to C&EN that “we’re not spelling our product name, Noble, the way the Swedish Nobel Foundation does.” Ethicist Michael Kalichman has a different perspective. Use of the word Noble, even though spelled differently than the prize, is “unseemly but not illegal,” he says. Kalichman, who is director of the Research Ethics Program at the University of California, San Diego, adds, “If his goal is to make money, this may work. But if his goal is to retain credibility and pursue other more laudable goals, maybe he should stay focused on those goals.”
Botros says PanaceaNano is also developing nanotechnology materials for markets including hydrogen storage, flexible batteries, and molecular memory based on technology from Stoddart’s lab and licensed from Northwestern University. But PanaceaNano chose to make its first commercial product a line of cosmetics because of the high margins and the ease of market entry.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter